Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Edesa Biotech Inc.
Headquarters:
Markham, ON, Canada
Website:
http://www.edesabiotech.com
Year Founded:
2015
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Pardeep Nijhawan, MD
Number Of Employees:
16
Enterprise Value:
$13,211,081
PE Ratio:
-1.21
Exchange/Ticker 1:
NASDAQ:EDSA
Exchange/Ticker 2:
N/A
Latest Market Cap:
$16,011,700
BioCentury
|
Sep 21, 2021
Product Development
Sept. 20 Quick Takes: Seagen, Genmab prepping launch of ADC for cervical cancer
EC pressures Illumina, Grail; March PDUFA date for Bristol’s LAG3 combo; biosimilar Lucentis approval and more
Read More
BioCentury
|
Apr 21, 2020
Product Development
Trio of tactics to target COVID-19 hyperinflammation
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Read More
BioCentury
|
Jun 27, 2016
Company News
Cipher, Edesa Biotech deal
Read More
Items per page:
10
1 - 3 of 3